Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.84, $0.23 worse than the analyst estimate of $9.07. Revenue for the quarter came in at $49.4 billion versus the consensus estimate of $48.14 billion.

GUIDANCE:

Elevance Health Inc. sees FY2025 EPS of $30.00, versus the consensus of $34.48.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.